市場調查報告書
商品編碼
1470564
細胞增殖市場:按產品、細胞類型、應用和最終用戶 - 2024-2030 年全球預測Cell Expansion Market by Product (Consumables, Instruments), Cell Type (Animal Cells, Human Cells), Application, End-User - Global Forecast 2024-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
細胞增殖市場規模預估2023年為193.6億美元,2024年達209億美元,預估2030年將達337億美元,複合年成長率為8.23%。
細胞增殖是指從少量的初始群體中培養大量的細胞。該程序是生物技術各領域的基礎,包括藥物開發、再生醫學和臨床研究。該過程涉及在受控條件下培養細胞並增加其數量,同時保持特定的特性和功能。細胞增殖對於確保研究人員和臨床醫生擁有足夠數量的細胞用於治療應用、研究或進一步的生物製造過程至關重要。細胞培養技術、反應器和自動化方面的創新提高了細胞生長過程的可擴展性和效率。全球糖尿病、癌症和心血管疾病盛行率的不斷上升正在推動對再生療法和生物製藥的需求,從而推動細胞增殖市場的成長。然而,與細胞生長設備和消耗品相關的成本對市場成長構成了挑戰。對個人化醫療和患者特異性治療的日益關注正在為細胞增殖市場創造成長機會。
主要市場統計 | |
---|---|
基準年[2023] | 193.6億美元 |
預測年份 [2024] | 209億美元 |
預測年份 [2030] | 337億美元 |
複合年成長率(%) | 8.23% |
產品:由於在研究和生物製藥製造中必須重複使用,因此擴大了細胞增殖消耗品的使用
消耗品是指在細胞生長過程中定期使用和更換的產品,例如試劑、培養基、血清和一次性反應器系統。這些材料對於試管內細胞的維持和生長至關重要。拋棄式是指一次性物品,例如旨在防止污染並確保細胞生長的無菌環境的燒瓶、板和管子。這些對於在細胞生長過程中維持細胞培養完整性至關重要。培養基是指細胞生長和增殖所需的富含營養的溶液。培養基必須精心配製,以滿足目標細胞群的特定需求,確保最佳的生長結果。試劑促進細胞生長所需的生物反應和過程,例如分化和增殖。血清提供必需的生長因子、荷爾蒙和營養物質並支持細胞生長。儘管無血清培養基往往在更受控的條件下使用,但血清對於許多細胞類型仍然很重要。細胞生長涉及的設備包括該過程必需的硬體和設備,例如反應器、細胞培養容器和離心機。這些設備促進細胞生長所需的受控環境,並確保維持最佳生長的精確條件。自動化細胞擴增系統可提供更高的精度和控制,從而實現可擴展的細胞擴增,同時減少勞動力並降低污染風險。該系統是細胞培養領域的重要技術進步。微載體反應器利用微載體為懸浮培養中貼壁細胞的生長提供表面,促進受控環境中的大規模細胞生長。灌注或中空纖維反應器透過連續向培養物添加新鮮培養基並移除廢棄物,維持最佳生長條件並生長緻密的細胞群。細胞計數器和血球計數器對於監測細胞密度和活力至關重要。這些工具確保增殖以所需的速度發生,並且細胞在整個過程中保持健康。離心機用於將細胞與培養基和其他溶液分離。離心機對於細胞擴增工作流程中的細胞收穫和下游處理至關重要。流式細胞儀提供細胞群的詳細分析,包括活力、純度和表現型特徵,確保擴增細胞的品質和一致性。
應用:L在再生醫學、全球再生治療幹細胞研究的擴展
細胞增殖透過促進腫瘤生長動力學和各種藥物對癌細胞影響的研究,在癌症和細胞研究中發揮至關重要的作用。此應用對於識別潛在的癌症治療方法和了解細胞層面的癌症生物學至關重要,並描述了開發更有效治療方法的途徑。在再生醫學和幹細胞研究領域,細胞增殖對於產生足夠數量的細胞用於組織再生和修復等治療應用至關重要。透過利用幹細胞的力量來替換或修復受損的組織和器官,這個過程支持開發多種疾病(包括退化性疾病)的治療方法,並加速個人化醫療的進步。
區域洞察
美國憑藉其強大的生物技術和製藥行業、對研發 (R&D) 的大量投資以及行業領先參與企業的強大影響力,在美洲細胞增殖市場中佔據主導地位。該地區在研究和治療應用方面對尖端技術的採用率很高,例如自動化細胞生長系統和反應器。加拿大和巴西細胞增殖市場的良好成長歸因於政府對醫學研究的資助增加、需要細胞治療的慢性疾病盛行率上升以及對幹細胞研究和治療開發的監管支持。由於經濟成長、醫療保健支出增加以及對生物技術研究的日益關注,亞太地區正在成為細胞增殖市場的一個充滿活力的地區。中國、日本、韓國和澳洲等國家處於領先地位,在幹細胞研究和再生醫學方面投入大量資金。中國細胞增殖的顯著成長是由政府加強生物技術研究的努力所推動的。日本強大的製藥業和有利的再生醫學法規環境為該地區該領域的市場開拓提供了重大進展。歐洲/中東/非洲地區呈現出多元化的市場格局,歐洲技術進步、研發活動和細胞治療方法的採用都取得了重大進展。德國、英國和法國是重要的貢獻者,並得到了有利的政府政策、廣泛的研究基礎設施以及學術界和工業界之間的合作的支持。由於生物技術研究活動的增加、醫療基礎設施投資的增加以及需要先進治療方法的慢性病盛行率的增加,非洲地區的細胞增殖市場正在不斷成長。
FPNV定位矩陣
FPNV定位矩陣對於評估細胞增殖市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標,以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估,供應商被分為四個成功程度不同的像限。最前線 (F)、探路者 (P)、利基 (N) 和重要 (V)。
市場佔有率分析
市場佔有率分析是一種綜合工具,可以對細胞增殖市場中供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻,以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外,該分析還提供了對該細分市場競爭特徵的寶貴見解,包括在研究基準年觀察到的累積、碎片化主導地位和合併特徵等因素。詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略,從而在市場上獲得競爭優勢。
1. 市場滲透率:提供有關主要企業所服務的市場的全面資訊。
2. 市場開拓:我們深入研究利潤豐厚的新興市場,並分析其在成熟細分市場的滲透率。
3. 市場多元化:包括新產品發布、開拓地區、最新發展和投資的詳細資訊。
4.競爭評估與資訊:對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。
5. 產品開發與創新:包括對未來技術、研發活動和突破性產品開發的智力見解。
1. 細胞增殖市場的市場規模與預測是多少?
2.在細胞增殖市場的預測期內,我們應該考慮投資哪些產品和應用?
3. 細胞增殖市場的技術趨勢和法規結構是什麼?
4.細胞增殖市場主要廠商的市場佔有率是多少?
5. 進入細胞增殖市場的合適形式和策略手段是什麼?
[197 Pages Report] The Cell Expansion Market size was estimated at USD 19.36 billion in 2023 and expected to reach USD 20.90 billion in 2024, at a CAGR 8.23% to reach USD 33.70 billion by 2030.
Cell expansion refers to cultivating a large number of cells from a small initial population. This procedure is fundamental to various fields within biotechnology, including drug development, regenerative medicine, and clinical research. The process involves cultivating cells under controlled conditions to increase their number while maintaining their specific characteristics or functionality. Cell expansion is crucial in enabling researchers and clinicians to have sufficient quantities of cells for therapeutic applications, research studies, or further biological manufacturing processes. The innovations in cell culture technologies, bioreactors, and automation have improved the scalability and efficiency of cell expansion processes. The growing incidence of diabetes, cancer, and cardiovascular diseases globally drives demand for regenerative therapies and biopharmaceuticals, fueling the growth of the cell expansion market. However, the expenses associated with cell expansion instruments and consumables challenges the market growth. The increasing focus on personalized medicine and patient-specific treatments offers opportunities for the growth of the cell expansion market.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 19.36 billion |
Estimated Year [2024] | USD 20.90 billion |
Forecast Year [2030] | USD 33.70 billion |
CAGR (%) | 8.23% |
Product: Expanding use of consumables in cell expansion due to their essential, repetitive use in research and biopharmaceutical production
Consumables refer to products such as reagents, media, sera, and disposable bioreactor systems that are regularly used and replaced throughout the cell expansion. These materials are crucial for the maintenance and proliferation of cells in vitro. Disposables are single-use items such as flasks, plates, and tubes designed to prevent contamination and ensure a sterile environment for cell growth. They are crucial for maintaining the integrity of cell cultures during the expansion process. Media refers to the nutrient-rich solutions required for cell growth and proliferation. Media must be carefully formulated to meet the specific needs of the target cell population, ensuring optimal expansion outcomes. Reagents facilitate biological reactions and processes necessary for cell growth, such as differentiation and proliferation. Sera provides essential growth factors, hormones, and nutrients that support cell expansion. Despite the trend towards serum-free media for more controlled conditions, sera remains crucial for many cell types. Instruments in cell expansion encompass the hardware and devices essential for the process, including bioreactors, cell culture vessels, and centrifuges. These instruments facilitate the controlled environment necessary for cell growth, ensuring precise conditions are maintained for optimal expansion. Automated cell expansion systems offer higher precision and control, enabling scalable cell expansion with reduced labor and a lower risk of contamination. They represent an essential technological advancement in the field of cell culture. Microcarrier bioreactors utilize microcarriers that provide a surface for adherent cells to grow in a suspended culture, facilitating large-scale cell expansion in a controlled environment. Perfusion or hollow fiber bioreactors operate by continuously feeding fresh media into the culture while removing waste, maintaining optimal growth conditions and expanding high-density cell populations. Cell counters & hemocytometers are essential for monitoring cell density and viability; these tools ensure that expansion proceeds at the desired pace and that cells remain healthy throughout the process. Centrifuges are used to separate cells from media and other solutions; centrifuges are vital for cell harvesting and downstream processing in the expansion workflow. Flow cytometers provide detailed analysis of cell populations, including viability, purity, and phenotypic characteristics, ensuring the quality and consistency of expanded cells.
Application: ell expansion in regenerative medicine & stem cell research for regenerative treatments globally
In cancer and cell-based research, cell expansion plays a pivotal role by facilitating the study of tumor growth kinetics and the effects of various drugs on cancer cells. This application is critical for identifying potential cancer treatments and understanding cancer biology at a cellular level, thus offering a pathway toward developing more effective therapies. Within regenerative medicine and stem cell research, cell expansion is indispensable for generating sufficient quantities of cells required for therapeutic applications, such as tissue regeneration and repair. This process supports the development of treatments for various conditions, including degenerative diseases, by harnessing the power of stem cells to replace or repair damaged tissues and organs, furthering the advancement of personalized medicine.
Regional Insights
The United States dominates the cell expansion market in the Americas due to its robust biotechnology and pharmaceutical sectors, significant investments in research and development (R&D), and strong presence of leading industry players. The region witnesses a high adoption rate of advanced technologies, including automated cell expansion systems and bioreactors, catering to research and therapeutic applications. The promising growth of the cell expansion market in Canada and Brazil can be attributed to increased government funding for healthcare research, the rising prevalence of chronic diseases requiring cell therapy treatments, and regulatory support for stem cell research and therapy development. The Asia-Pacific region is emerging as a dynamic area in the cell expansion market, driven by economic growth, growing healthcare expenditure, and an increasing focus on biotechnology research. Countries like China, Japan, South Korea, and Australia are at the forefront, investing significantly in stem cell research and regenerative medicine. China's significant growth in cell expansion is propelled by governmental efforts to enhance biotechnology research. Japan's robust pharmaceutical sector and favorable regulatory environment for regenerative medicine majorly advance the region's market development in this field. The EMEA region showcases a diverse landscape for the cell expansion market, with Europe showcasing significant technological advancement, R&D activities, and adoption of cell-based therapies. Germany, the United Kingdom, and France are vital contributors, supported by favorable government policies, extensive research infrastructure, and collaborations between academia and industry. The cell expansion market in the African region is growing, driven by increasing research activities in biotechnology, rising investments in healthcare infrastructure, and the growing prevalence of chronic diseases requiring advanced therapeutic approaches.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Cell Expansion Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Cell Expansion Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Cell Expansion Market, highlighting leading vendors and their innovative profiles. These include Becton, Dickinson and Company, Bio-Techne Corporation, Celltainer Biotech B.V., Corning Incorporated, Cytiva, Danaher Corporation, Eppendorf SE, G&G Technologies, Inc., GE Healthcare, iXCells Biotechnologies, Lonza Group Ltd., Merck KGaA, Miltenyi Biotec B.V. & Co. KG, Neuromics, NexImmune, Novartis AG, PromoCell GmbH, REPROCELL Inc., Sartorius AG, Scinus Cell Expansion, Stemcell Technologies, Inc., Takara Bio Inc., Terumo BCT, TERUMO BCT, INC., and Thermo Fisher Scientific, Inc..
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Cell Expansion Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Cell Expansion Market?
3. What are the technology trends and regulatory frameworks in the Cell Expansion Market?
4. What is the market share of the leading vendors in the Cell Expansion Market?
5. Which modes and strategic moves are suitable for entering the Cell Expansion Market?
TABLE 3